The impact of palivizumab reimbursement criteria on neonatal RSV hospitalizations and drug prescriptions: an area-based cohort study from the Tuscany Region, Italy

Vieri Lastrucci,Giorgia Alderotti, Martina Pacifici,Lorenzo Stacchini, Monia Puglia, Elettra Berti,Giulia Hyeraci,Giuseppe Roberto,Rosa Gini,Fabio Voller

Population medicine（2023）

引用 0|浏览4

暂无评分

摘要

Background and Objective: Respiratory syncytial virus (RSV) is a leading cause of hospitalization in infants aged 29 weeks. The study aimed to evaluate the impact of the 2016 restrictions (intervention) on RSV hospitalizations and palivizumab prescriptions for infants aged

查看译文

关键词

neonatal rsv hospitalizations,palivizumab reimbursement criteria,drug prescriptions,cohort study,area-based

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要